RIDASCREEN® Spec. IgG Foodscreen Plate 1
Intended use:For in vitro diagnostic use. The RIDASCREEN® Spec. IgG Foodscreen test is a quantitative or qualitative enzyme immunoassay (EIA) for the detection of specific IgG antibodies against [...]
Dear customers,
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
RIDASCREEN® Spec. IgG Foodscreen Plate 2
Intended use:For in vitro diagnostic use. The RIDASCREEN® Spec. IgG Foodscreen test is a quantitative or qualitative enzyme immunoassay (EIA) for the detection of specific IgG antibodies against [...]
RIDASCREEN® Spec. IgG Foodscreen Plate 3
Intended use:For in vitro diagnostic use. The RIDASCREEN® Spec. IgG Foodscreen test is a quantitative or qualitative enzyme immunoassay (EIA) for the detection of specific IgG antibodies against [...]
RIDASCREEN® Spec. IgG Foodscreen Plate 6
Intended use:For in vitro diagnostic use. The RIDASCREEN® Spec. IgG Foodscreen test is a quantitative or qualitative enzyme immunoassay (EIA) for the detection of specific IgG antibodies against [...]
RIDASCREEN® Spec. IgG Foodscreen Customized Plate
Intended use:For in vitro diagnostic use. The RIDASCREEN® Spec. IgG Foodscreen test is a quantitative or qualitative enzyme immunoassay (EIA) for the detection of specific IgG antibodies against [...]
Delayed food allergies
Smart idea with high performance: Microspot arrays revolutionize clinical diagnostics
Microspot arrays facilitate efficient and high-quality multiplex diagnostics for any sample throughput. They are also convenient, flexible, and automatable. This innovative technology is [...]
Type I allergies
Tuberculosis
Tuberculosis remains the world’s leading infectious disease killer. WHO – Global tuberculosis report 2024 In 2023, 10.8 million people fell ill with Tuberculosis and 1.25 million lost [...]
Interview: Tuberculosis Diagnostics at R-Biopharm
“Early and consistent tuberculosis detection to break infection chains and eliminate the disease worldwide” R-Biopharm has launched a new generation of diagnostics for the global [...]